A Submicron Lipid Emulsion Coated with Amphipathic Polyethylene Glycol for Parenteral Administration of Paclitaxel (Taxol)
Open Access
- 1 January 1997
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 49 (1), 16-21
- https://doi.org/10.1111/j.2042-7158.1997.tb06744.x
Abstract
Paclitaxel is a promising anticancer agent with poor solubility in water and requires a suitable formulation for intravenous administration. PresentlyKeywords
This publication has 26 references indexed in Scilit:
- Submicron lipid emulsions containing amphipathic polyethylene glycol for use as drug-carriers with prolonged circulation timeInternational Journal of Pharmaceutics, 1996
- Solvent- and Concentration-Dependent Molecular Interactions of Taxol (Paclitaxel †)Journal of Pharmaceutical Sciences, 1994
- Differential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant sublinesin vitroInvestigational New Drugs, 1994
- Taxol-Lipid Interactions: Taxol-Dependent Effects on the Physical Properties of Model MembranesBiochemistry, 1994
- Preparation of Drug-Carrier Emulsions Stabilized with Phosphatidylcholine-Surfactant MixturesJournal of Pharmaceutical Sciences, 1994
- A Mixed Micellar Formulation Suitable for the Parenteral Administration of TaxolPharmaceutical Research, 1994
- Cytotoxic studies of paclitaxel (Taxol®) in human tumour cell linesBritish Journal of Cancer, 1993
- Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast CancerJNCI Journal of the National Cancer Institute, 1991
- Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivoBiochimica et Biophysica Acta (BBA) - Biomembranes, 1991
- Delivery of Novel Therapeutic Agents in Tumors: Physiological Barriers and StrategiesJNCI Journal of the National Cancer Institute, 1989